UBS Group AG

Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.12 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$31,552,425	899,442	+130,922	+17%	$35.08	Q4 2025
30 Sep 2025	0%	+0%	$21,856,709	768,520	+140,801	+22%	$28.44	Q3 2025
30 Jun 2025	0%	+0%	$11,367,992	627,719	+229,576	+58%	$18.11	Q2 2025
31 Mar 2025	0%	+0%	$8,149,987	398,143	+317,933	+300%	$20.47	Q1 2025
31 Dec 2024	0%	-0%	$2,061,397	80,210	-50,030	-38%	$25.70	Q4 2024
30 Sep 2024	0%	+0%	$2,161,984	130,240	+124,171	+2046%	$16.60	Q3 2024
30 Jun 2024	0%	-0%	$116,586	6,069	-42,210	-87%	$19.21	Q2 2024
31 Mar 2024	0%	+0%	$1,141,799	48,279	+47,479	+5935%	$23.65	Q1 2024
31 Dec 2023	0%	+0%	$8,936	800	+800	NEW	$11.17	Q4 2023
30 Sep 2023		-0%	$0	0	-183	-100%	$34.30	Q3 2023
30 Jun 2023	0%	+0%	$2,176	183	+183	NEW	$11.89	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.